Virtus Fund Advisers, LLC
- SEC CIK
- 0001319111
- Latest filing
- Feb 14, 2025
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Virtus Fund Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q4 2024 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2022